Subchronic racemic gamma vinyl-GABA produces weight loss in Sprague Dawley and Zucker fatty rats

Synapse

Volumn 62, Issue 11, 2008, Pages 870-872

  DeMarco, Amy ^a   Dalal, Reema M ^b   Kahanda, Milan ^a   Mullapudi, Uma ^c   Pai, Jessica ^b   Hammel, Crystie ^a   Liebling, Courtney N B ^a   Patel, Vinal ^a   Brodie, Jonathan D ^b   Schiffer, Wynne K ^a   Dewey, Stephen L ^a   Aquilina, Stefanie D ^d  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c DARTMOUTH COLLEGE   (United States)

^d Department of Obstetrics Gynecology   (United States)

Author keywords

Binge eating disorder; GABA; Obesity; Vigabatrin; Zucker fatty rat

Indexed keywords

VIGABATRIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; EXPERIMENTAL MODEL; FOOD INTAKE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RACEMIZATION; RAT; SPRAGUE DAWLEY RAT; TREATMENT DURATION; WEIGHT REDUCTION; ZUCKER RAT;

AGE FACTORS; ANIMALS; BODY WEIGHT; CHRONOTHERAPY; INJECTIONS, INTRAPERITONEAL; MALE; OBESITY; RATS; RATS, SPRAGUE-DAWLEY; RATS, ZUCKER; VIGABATRIN; WEIGHT LOSS;

EID: 52249089584     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20555     Document Type: Article

References (16)

1. Bray GA. 1977. The Zucker-fatty rat: A review. Fed Proc 36:148-153.
2. Brodie JD, Figueroa E, Laska EM, Dewey SL. 2005. Safety and efficacy of γ-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction. Synapse 55:122-125.
3. Cooper BR, Howard JL, White HL, Soroko F, Ingold K, Maxwell RA. 1980. Anorexic effects of ethanolamine-O-sulfate and muscimol in the rat: evidence that GABA inhibits ingestive behavior. Life Sci 26:1997-2002.
4. Dewey SL, Morgan AE, Ashby CR Jr, Horan B, Kushner SA, Logan J, Volkow ND, Fowler JS, Gardner EL, Brodie JD. 1998. A novel strategy for the treatment of cocaine addiction. Synapse 30:119-129.
5. Fechtner RD, Khouri AS, Figueroa E, Ramirez M, Federico M, Dewey SL, Brodie JD. 2006. Short-term treatment of cocaine and/or methamphetamine abuse with vigabatrin: Ocular safety pilot results. Arch Ophthalmol 124:1257-1262.
6. Gerasimov MR, Ashby CR, Jr., Gardner EL, Mills MJ, Brodie JD, Dewey SL. 1999. Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine. Synapse 34:11-19.
7. Howard JL, Cooper BR, White HL, Soroko FE, Maxwell RA. 1980. A role for GABA in the control of ingestive behavior in rats: Effects of ethanolamine-O-sulfate and muscimol. Brain Res Bull 5:595-599.
8. Huot S, Palfreyman MG. 1982. Effects of γ-vinyl GABA on food intake in rats. Pharmacol Biochem Behav 17:99-106.
9. Jung MJ, Lippert B, Metcalf BW, Bohlen P, Schechter PJ. 1977. γ-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: Effects on brain GABA metabolism in mice. J Neurochem 29:797-802.
10. Kurtz TW, Morris RC, Pershadsingh HA. 1989. The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension 13:896-901.
11. Kushner SA, Dewey SL, Kornetsky C. 1999. The irreversible γ-aminobutyric acid (GABA) transaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats. J Pharmacol Exp Ther 290:797-802.
12. Mazurkiewicz M, Sirviö J, Riekkinen P, Sr. 1993. Effects of single and repeated administration of vigabatrin on the performance of non-epileptic rats in a delayed non-matching to position task. Epilepsy Res 15:221-227.
13. Morgan AE, Dewey SL. 1998. Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine. Synapse 28:60-65.
14. Paterson NE, Markou A. 2002. Increased GABA neurotransmission via administration of gamma-vinyl GABA decreased nicotine self-administration in the rat. Synapse 44:252-253.
15. Rada P, Mendialdua A, Hernandez L, Hoebel BG. 2003. Extracellular glutamate increases in the lateral hypothalamus during meal initiation, and GABA peaks during satiation: microdialysis measurements every 30 s. Behav Neurosci 117:222-227.
16. Williams PM, Goodie J, Motsinger CD. 2008. Treating eating disorders in primary care. Am Fam Physician 77:187-195.